🔗 Share this article Social Media Content Creators Fueling Parallel Market for Unlicensed Slimming Medication A shadow economy for unlicensed slimming drugs is being driven by social media fitness personalities and sellers on communication apps, according to recent findings. Investigational Treatment Gaining Traction Via Social Media The experimental drug, which is still in clinical trials, is being advertised by social media influencers for its alleged fat-burning properties. Viewers are urged to contact these profiles privately for source information, while also receiving discount codes. Thriving Trade on Social Networks Separately, a robust trade exists on Telegram, where groups with thousands of members share “before and after” images, injection guides and claims of rapid UK delivery. Vendors promote the substance there before redirecting customers to other platforms for purchases. Understanding The Experimental Drug Retatrutide is an investigational injection developed by US drugmaker Eli Lilly. The treatment targets three gut hormones – GLP-1, GIP and glucagon. Early trials suggest it could assist patients reduce up to 25% of their body weight. Nicknamed the “triple G”, the substance is being hailed online as the next Ozempic. Medical Professionals Voice Concerns Nevertheless, doctors and pharmacists have warned that the distribution of what remains an unapproved medication in the UK is worrisome and could result in users injecting products of uncertain source. Several professionals stated the popularity for retatrutide could be linked to the increasing price of licensed weight loss treatments such as Mounjaro. Legal Position and Enforcement Selling retatrutide on TikTok or messaging apps is illegal in the UK, as it is an unlicensed medication that must not be marketed or supplied for human use under the British medical regulations. Some content creators attempt to circumvent the rules by referring to the substance as a “research chemical” or describing it as “not for human consumption”. Retatrutide is not a restricted substance, but promotion and supply can still breach medicines, advertising, and consumer regulations, potentially leading to penalties, legal action or imprisonment. Service Reaction and Material Removal Based on TikTok, the service has taken down violative content and banned related keywords and search suggestions. The company said it was committed to keeping the service safe and investing in strengthening enforcement strategies. Online Trading Activities Research also discovered communities with up to nine thousand members selling the experimental drug using Telegram's built-in search feature, which operates like a public directory. Entering “retatrutide” immediately displays groups with thousands of members, populated with images of slimming results, glowing reviews and detailed instructions for preparing or administering at residence. Within minutes of joining one group, a vendor shared contact information, where most purchases occur. The seller provided an guidebook and promised shipping within two days. When asked whether the product was authentic, one seller said: “You can’t be sure.” Another provided a photo of a supposed testing documentation. None inquired about weight, medical conditions or past usage. Item Information and Pricing Within these communities, messages show dark colored parcels with Royal Mail labels, stating to include new batches. One communication stated: “It took eight of us to load them this morning.” Customers can choose between dry substance containers, mixed at home with purified liquid, or ready-to-use pens typically priced at 160 pounds for 20mg. When questioned how long a pen should be used, sellers give contradictory responses varying between a several days to “depends on your body”. Service Oversight and Security Actions A spokesperson for the messaging service stated it actively moderated harmful content on its service including content that encouraged the “misuse of controlled medications”. The company noted that it eliminated “millions of pieces of harmful content each day”. Healthcare Professional Cautions “People are administering materials they cannot confirm. Although the research behind retatrutide is sound, these online versions may not include what they claim,” stated Jason Murphy, the director of pharmacy at Chemist4U. A medical professional of an online medical service connected the surge in interest to recent price rises for authorized slimming medications such as Mounjaro. “With costs rising, individuals are using social media. But fake treatments are extremely dangerous. You can’t be certain what’s contained or whether the environment they were made in was sterile,” she explained. Her team has previously seen patients harmed by personal administration from unconfirmed suppliers. “We understand the disappointment, but buying from messaging apps or communication platforms is taking chances with your well-being,” stated Wyllie. “These materials could be contaminated or incorrectly dosed.” Producer Position A representative from the pharmaceutical company said the substance was in phase 3 clinical trials and had not been evaluated or approved by any regulatory agency anywhere in the world. “Therefore at this point no one can sell [it] for personal consumption,” they explained, adding that any item “falsely representing itself as a Lilly investigational substance not yet approved … may subject patients to potentially significant health risks”.